142.5083
173.6246
1
1 Lakh
Investment Grown to₹ 10000
Monthly SIP Grown toSuitability:
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.
Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.
Taxability of earnings:
Capital gains
Dividends
Please wait...
Please wait...
| YTD | 1-Day | 1-W | 1-M | 3-M | 6-M | 1-Y | 3-Y | 5-Y | 7-Y | 10-Y | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| UTI Healthcare Reg-G | -14.12 | 1.04 | 0.48 | -8.45 | -6.29 | -11.63 | -7.51 | 22.17 | 10.95 | 6.42 | 13.65 |
| S&P BSE Healthcare TRI | -13.37 | 1.32 | 1.10 | -8.98 | -5.75 | -11.06 | -5.43 | 20.58 | 9.27 | 5.25 | 13.81 |
| Equity: Sectoral-Pharma | -12.92 | 1.20 | 0.95 | -8.49 | -5.42 | -10.30 | -5.09 | 23.75 | 11.95 | 7.74 | 15.34 |
| Rank within category | 12 | 12 | 11 | 7 | 13 | 14 | 9 | 7 | 3 | 2 | 3 |
| Number of funds in category | 14 | 14 | 14 | 14 | 14 | 14 | 9 | 8 | 4 | 3 | 3 |
As on 17-May-2022
| Fund name | Rating | Launch Date | 1-Year Return | 3-Year Return | 5-Year Return | Expense Ratio | Assets (Cr) |
|---|---|---|---|---|---|---|---|
| UTI Healthcare Fund - Regular Plan | Invest Online | Jun-99 | -7.51 | 22.17 | 10.95 | 2.30% | 766 | |
| Nippon India Pharma Fund | Jun-04 | -5.44 | 24.25 | 15.75 | 1.78% | 4,851 | |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | Invest Now | Jul-18 | -6.73 | 23.90 | -- | 2.36% | 2,392 | |
| Mirae Asset Healthcare Fund - Regular Plan | Invest Online | Jul-18 | -1.08 | 27.49 | -- | 2.05% | 1,790 | |
| SBI Healthcare Opportunities Fund | Invest Online | Jul-99 | -7.27 | 22.39 | 9.55 | 2.21% | 1,763 |
| Best Performance | Worst Performance | |||
|---|---|---|---|---|
| Return (%) | Period | Return (%) | Period | |
| Week | 21.24 | 01-Apr-2020 - 09-Apr-2020 | -16.12 | 15-Jan-2008 - 22-Jan-2008 |
| Month | 34.24 | 23-Mar-2020 - 22-Apr-2020 | -31.35 | 09-May-2006 - 08-Jun-2006 |
| Quarter | 44.96 | 23-Mar-2020 - 22-Jun-2020 | -27.70 | 02-Sep-2008 - 03-Dec-2008 |
| Year | 99.77 | 25-Mar-2009 - 25-Mar-2010 | -26.83 | 31-Dec-2007 - 30-Dec-2008 |
| Mean | Std Dev | Sharpe | Sortino | Beta | Alpha | |
|---|---|---|---|---|---|---|
| UTI Healthcare Reg-G | 21.72 | 20.90 | 0.87 | 1.86 | 0.92 | 2.35 |
| S&P BSE Healthcare TRI | 20.70 | 22.26 | 0.77 | 1.54 | -- | -- |
| Equity: Sectoral-Pharma | 23.23 | 20.13 | 0.98 | 2.02 | 0.88 | 4.59 |
| Rank within category | 7 | 6 | 8 | 6 | 6 | 8 |
| Number of funds in category | 8 | 8 | 8 | 8 | 8 | 8 |
The Risk Measures have been calculated using calendar month returns for the last three years.
As on 30-Apr-2022
Please wait...
| Number of Stocks | 31 |
| Top 10 Stocks (%) | 57.11 |
| Top 5 Stocks (%) | 36.77 |
| Top 3 Sectors (%) | 98.34 |
| Portfolio P/B Ratio | 4.25 |
| Portfolio P/E Ratio | 28.90 |
| Fund | Category | |
|---|---|---|
| Average Mkt Cap (Rs Cr) | 35,171 | 58,227 |
| Giant (%) | 11.04 | 19.29 |
| Large (%) | 29.24 | 37.16 |
| Mid (%) | 48.79 | 37.19 |
| Small (%) | 10.33 | 6.71 |
| Tiny (%) | 0.61 | 0.73 |
Please wait...
Indicates an increase or decrease or no change in holding since last portfolio
Indicates a new holding since last portfolio
As on 30-Apr-2022
— Kamal Gada since 02-May-2022
Education: Mr. Gada is B.com, CA, CS, & CFA
Experience: Prior to joining UTI Mutual Fund he has worked with BPCL as Senior Accounts Officer.
— V Srivatsa since 02-Mar-2017
Education: Mr. Srivatsa is a B.Com (H), Chartered Accountant, CWA. and PGDM from IIM Indore.
Experience: Prior to joining UTI in 2002 he has worked with Ford, Rhodes Parks & Co., Chartered Accountants and Madras Cements Ltd.
Funds Managed:
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
| Min. Investment (₹) | 5,000 |
| Min. Addl Investment (₹) | 1,000 |
| Min. SIP Investment (₹) | 500 |
| Min. No of Cheques | 6 |
| Min. Withdrawal (₹) | -- |
| Min. Balance (₹) | 5,000 |
| Lock-in Period | Not Applicable |
| Exit Load | 1% for redemption within 30 days |
| Fund House: | UTI Mutual Fund |
| Launch Date: | 28-Jun-1999 |
| Return Since Launch: | 13.76% |
| Benchmark: | S&P BSE Healthcare TRI |
| Riskometer: | Very High |
| Type: | Open-ended |
| Assets: | ₹ 766 Cr (As on 30-Apr-2022) |
| Expense: | 2.30% (As on 31-Mar-2022) |
| Risk Grade: | -- |
| Return Grade: | -- |
| Turnover: | 44.00% |
| Plan | Record Date | Dividend (₹ / Unit) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDCW | 28-Oct-2010 | 1.7000 | |||||||||||||||||
| |||||||||||||||||||
AMC: UTI Asset Management Company Ltd
Address: 1st Floor, Signature, Office No.103 Valsad Dharampur Road Mumbai - 396001
Phone: 0263 2296993
Fax: (0260) 2421315
Website: http://www.utimf.com
Registrar & Transfer Agent: KFin Technologies Ltd.
Address: 303, Vamsee Estates, Opp. Big Bazaar, Ameerpet, Hyderabad - 500016
Phone: 040-44857874
Email: [email protected]
Website: www.karvymfs.com
You have reserved a spot
Friday, 20-May-2022
12:30 PM - 12:40 PM